Funding mechanism: This dimension captures the way treatment of obesity is funded, i.e., reimbursed vs
Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
There are several studies demonstrating that CR and IF may develop the protective effects of mitochondria, but the exact mechanisms underlying the improvement in mitochondrial function and dynamics are not fully understood
N Engl J Med , 2023